Yuanli Chen Selected Research

Yuanli Chen Research Topics

Disease

34	Atherosclerosis 12/2023 - 06/2012
22	Inflammation (Inflammations) 12/2023 - 04/2014
13	Neoplasms (Cancer) 04/2024 - 06/2013
8	Insulin Resistance 12/2023 - 01/2019
8	Fatty Liver 01/2022 - 01/2018
7	Vascular Calcification 03/2024 - 10/2018
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2015
6	Breast Neoplasms (Breast Cancer) 04/2024 - 05/2015
6	Non-alcoholic Fatty Liver Disease 12/2023 - 02/2018
5	Sepsis (Septicemia) 10/2023 - 01/2016
5	Heart Failure 10/2023 - 03/2020
4	Neuroinflammatory Diseases 09/2023 - 05/2020
4	Cholestasis 01/2023 - 01/2019
4	Hypertriglyceridemia 01/2023 - 04/2015
4	Fibrosis (Cirrhosis) 04/2022 - 11/2019
4	Lung Injury 01/2022 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2014
4	Coronary Disease (Coronary Heart Disease) 01/2017 - 05/2014
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2023 - 01/2022
3	Necrosis 01/2023 - 11/2019
3	Hyperlipidemias (Hyperlipidemia) 01/2023 - 12/2018
3	Hypercholesterolemia 01/2023 - 01/2017
3	Obesity 01/2022 - 01/2020
3	Osteoradionecrosis 12/2021 - 01/2015
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2018
3	Vascular Diseases (Vascular Disease) 03/2020 - 01/2019
3	Dyslipidemias (Dyslipidemia) 01/2020 - 04/2015
2	Hypoxia (Hypoxemia) 01/2022 - 01/2022
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
2	Atrophy 03/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 11/2019

Drug/Important Bio-Agent (IBA)

18	Apolipoproteins E (ApoE)IBA 01/2023 - 04/2015
16	LipidsIBA 01/2024 - 06/2013
10	LigandsIBA 04/2024 - 12/2012
9	Liver X ReceptorsIBA 01/2021 - 12/2012
9	Capsules (Microcapsules)IBA 01/2021 - 01/2015
8	CholesterolIBA 12/2023 - 12/2012
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2018
7	T0901317IBA 01/2021 - 04/2014
7	naoxintongIBA 01/2021 - 01/2015
6	CytokinesIBA 10/2023 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 06/2015
5	Therapeutic UsesIBA 03/2024 - 01/2019
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 03/2020
5	Rosiglitazone (Avandia)FDA Link 01/2023 - 11/2019
5	ApolipoproteinsIBA 01/2023 - 05/2014
5	U 0126 (UO 126)IBA 01/2022 - 02/2015
5	Transcription Factors (Transcription Factor)IBA 06/2021 - 12/2012
5	CollagenIBA 03/2021 - 05/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2021
4	Fenofibrate (CiL)FDA LinkGeneric 12/2023 - 01/2019
4	AntioxidantsIBA 10/2023 - 09/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 03/2020
4	InterferonsIBA 01/2022 - 02/2015
4	LongShengZhiIBA 03/2020 - 01/2019
4	oxidized low density lipoproteinIBA 01/2020 - 12/2012
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2023 - 12/2020
3	InflammasomesIBA 10/2023 - 01/2016
3	AdiponectinIBA 01/2023 - 01/2017
3	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2019
3	IsoflavonesIBA 09/2022 - 01/2019
3	Adenosine Monophosphate (AMP)IBA 01/2022 - 02/2018
3	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2018
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2020
3	Collagen Type I (Type I Collagen)IBA 03/2021 - 11/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 11/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021 - 11/2019
3	Tamoxifen FDA LinkGeneric 12/2018 - 05/2015
3	trioctyl phosphine oxide (TOPO)IBA 12/2018 - 06/2013
3	Teniposide (VM 26)FDA Link 12/2018 - 06/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018 - 08/2015
3	buchang naoxintongIBA 01/2017 - 01/2015
3	Fatty Acid-Binding ProteinsIBA 08/2015 - 06/2012
2	EnzymesIBA 04/2024 - 03/2020
2	CateninsIBA 03/2024 - 07/2023
2	pitavastatin (itavastatin)FDA Link 01/2024 - 08/2015
2	KetonesIBA 12/2023 - 09/2022
2	pterostilbeneIBA 12/2023 - 10/2023
2	AMP-Activated Protein KinasesIBA 01/2023 - 01/2018
2	Sirtuin 3IBA 09/2022 - 03/2020
2	Pentoxifylline (Trental)FDA LinkGeneric 12/2021 - 01/2020
2	Vitamin E FDA LinkGeneric 12/2021 - 01/2020
2	Toll-Like Receptor 4IBA 03/2021 - 01/2021
2	Glutathione PeroxidaseIBA 03/2021 - 01/2020
2	CatalaseIBA 03/2021 - 03/2020
2	HydrogelsIBA 01/2021 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2021 - 12/2020
2	Urethane (Ethyl Carbamate)IBA 01/2021 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2019
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 05/2014
2	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 12/2020 - 01/2017

Therapy/Procedure

10	Therapeutics 12/2023 - 04/2015
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 01/2018
3	Ligation 11/2019 - 01/2016
2	Immunotherapy 01/2024 - 01/2023
2	Oral Administration 01/2021 - 01/2021